The most commonly utilized PET radionuclide is fluorine-18 ((18)F) because of its convenient half-life and excellent imaging properties. In this review, we present the first analysis of patents issued for radiotracers labeled with fluorine-18 (between 2009 and 2015), and provide perspective on current trends and future directions in PET radiotracer development.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561792 | PMC |
| http://dx.doi.org/10.4155/ppa.15.36 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at F-SynVesT-1 Brain PET Imaging.
Radiology
November 2024
From the Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, China (J. Wu, J. Wang, Q.H., K.H., Y.G., F.X.); Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (B.L.); Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China (X.C., Z.Y., J.Z.); Department of Gerontology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (Q.G.); PET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Conn (S.L., Y.H.H.); Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China (T.G.); Center for Applied Statistics, Institute of Statistics and Big Data, Renmin University of China, Beijing, China (W.D.); and Shanghai Conlight Medical Laboratory, Shanghai, China (W.X., W.C., D.Y.).
Background Synaptic loss is an important factor in Alzheimer disease (AD); however, blood assays that conveniently and rapidly reflect changes in synaptic density are lacking. Purpose To correlate multiple potential synaptic blood markers with synaptic density measured using F-SynVesT-1, a fluorine 18 (F)-labeled radiotracer, brain PET and to explore the independent associations between these markers and synaptic density. Materials and Methods This prospective study included 50 cognitively unimpaired (mean age, 65.
View Article and Find Full Text PDFAutomated radiofluorination of HER2 single domain antibody: the road towards the clinical translation of [F]FB-HER2 sdAb.
EJNMMI Radiopharm Chem
November 2024
Molecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Background: With the next generation of Human Epidermal Growth Factor Receptor 2 (HER2) -targeting therapies, such as antibody-drug conjugates, showing benefit in "HER2 low" and even "HER2 ultralow" patients, the need for novel methods to quantify HER2 expression accurately becomes even more important for clinical decision making. A HER2 PET/CT imaging assessment could evaluate HER2 positive disease locations while improving patient care, reducing the need for invasive biopsies. A single-domain antibody (sdAb)-based PET tracer could combine the high specificity of sdAbs with short-lived radionuclides such as fluorine-18 (F) and gallium-68 (Ga).
View Article and Find Full Text PDFPTB airway compression complicated by vascular abnormalities and cardiac involvement: A case series demonstrating diagnosis and management.
Pediatr Pulmonol
January 2025
Department of Forensic Medicine and Imaging, Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
Introduction: Lymphobronchial tuberculosis (LBTB) is a tuberculous lymphadenopathy causing airway compression in young children. While it can occur in older children due to factors such as airway size, wall weakness, and immune reconstitutions, severe airway obstruction is more common in younger children.
Methods: Chest X-rays show airway compression, while bronchoscopy is the gold standard for confirming TB-induced airway compression.
Synthesis of K channel radioligand [F]5-methyl-3-fluoro-4-aminopyridine and PET imaging in mice.
Bioorg Med Chem Lett
December 2024
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address:
Article Synopsis
- The compound [F]3-fluoro-4-aminopyridine ([F]3F4AP) is the first PET radioligand targeting K channels in the brain to image demyelination, but it shows lower metabolic stability in awake humans compared to anesthetized animals, affecting its brain uptake.!* -
- A new compound, 5-methyl-3-fluoro-4-aminopyridine (5Me3F4AP), has been developed, exhibiting similar binding affinity and properties to [F]3F4AP, but with a slower metabolic rate, making it a potential alternative for K channel imaging.!* -
- The synthesis of [F]5Me
[F]TFB PET/CT misses intense [I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
EJNMMI Res
October 2024
Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, P.O. Box 77, New York, NY, 10065, USA.
Article Synopsis
- The study investigates the effectiveness of Fluorine 18-labelled tetrafluoroborate ([F]TFB) as an imaging alternative to iodine for assessing metastatic thyroid cancer and potential radioiodine treatment success.
- Five patients participated in the research, receiving both [F]TFB and iodine imaging on the same day. Results showed that [F]TFB identified 58% of lesions compared to 91% for iodine imaging, indicating its lower sensitivity.
- The conclusion drawn highlights that [F]TFB did not successfully predict iodine uptake in patients undergoing redifferentiation therapy, raising questions about its reliability for other treatment cases or in untreated patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!